Blood test could prevent medication trial and error for rheumatoid arthritis patients

A molecule in the blood shows promise as a marker to predict whether individual rheumatoid arthritis patients are likely to benefit from biologic medications or other drugs should be tried, a study shows. The protein, analyzed in blood tests, may help avoid trial and error with medications, sparing patients treatment delays and unnecessary side effects and expense.

Leave a Reply

Your email address will not be published. Required fields are marked *